[
  {
    "ts": "2025-07-22T16:11:00+00:00",
    "headline": "WST Q2 Earnings Preview: Will the Stock's Segmental Edge Hold Up?",
    "summary": "West Pharmaceutical targets steady Q2 growth as high-value GLP-1 and SmartDose demand drives segment momentum.",
    "url": "https://finance.yahoo.com/news/wst-q2-earnings-preview-stocks-161100984.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "48f574d9-4b79-3769-a270-c05e5622a859",
      "content": {
        "id": "48f574d9-4b79-3769-a270-c05e5622a859",
        "contentType": "STORY",
        "title": "WST Q2 Earnings Preview: Will the Stock's Segmental Edge Hold Up?",
        "description": "",
        "summary": "West Pharmaceutical targets steady Q2 growth as high-value GLP-1 and SmartDose demand drives segment momentum.",
        "pubDate": "2025-07-22T16:11:00Z",
        "displayTime": "2025-07-22T16:11:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AeEW5pB2gJm.pEvDGN7i.A--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/18pxvSkCeCQtGDRu2e7mfw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/wst-q2-earnings-preview-stocks-161100984.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wst-q2-earnings-preview-stocks-161100984.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CAH"
            },
            {
              "symbol": "COR"
            },
            {
              "symbol": "WST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-22T14:08:44+00:00",
    "headline": "Barclays Cautious on West Pharma (WST) on Non-Core Weakness and Injectable Disruption Risks",
    "summary": "West Pharmaceutical Services Inc. (NYSE:WST) is one of the most oversold S&P 500 stocks so far in 2025. On June 24, Barclays analyst Luke Sergott began coverage on West Pharmaceutical Services (WST) with an Equal Weight rating and a price target of $245. In his view, while the company maintains a solid foothold in its core […]",
    "url": "https://finance.yahoo.com/news/barclays-cautious-west-pharma-wst-140844168.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "37c7936c-10fc-350a-b08f-22567d232b1e",
      "content": {
        "id": "37c7936c-10fc-350a-b08f-22567d232b1e",
        "contentType": "STORY",
        "title": "Barclays Cautious on West Pharma (WST) on Non-Core Weakness and Injectable Disruption Risks",
        "description": "",
        "summary": "West Pharmaceutical Services Inc. (NYSE:WST) is one of the most oversold S&P 500 stocks so far in 2025. On June 24, Barclays analyst Luke Sergott began coverage on West Pharmaceutical Services (WST) with an Equal Weight rating and a price target of $245. In his view, while the company maintains a solid foothold in its core […]",
        "pubDate": "2025-07-22T14:08:44Z",
        "displayTime": "2025-07-22T14:08:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/dc22020fc6a5bb75a846b3939233da29",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Barclays Cautious on West Pharma (WST) on Non-Core Weakness and Injectable Disruption Risks",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ybHk_gG_d_Hdv6gK8HlQyA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/dc22020fc6a5bb75a846b3939233da29.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oeGtj0wIY93757EL3GSrJQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/dc22020fc6a5bb75a846b3939233da29.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/barclays-cautious-west-pharma-wst-140844168.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/barclays-cautious-west-pharma-wst-140844168.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]